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Abstract 
The uncertain arrival of shocks can be modeled as a Poisson process.  When degradation takes place in very 
small increments almost continuously over time, a simpler and effective stochastic model of degradation can be 
derived as a limiting form of the compound poison process.  The limiting form is obtained when the rate of 
damage occurrence approaches infinity in any finite time interval as the size of the increment tends to zero.  
Such a stochastic process is referred to as a gamma process because the cumulative damage up to time t follows 
the gamma distribution.  The gamma process is suitable to model gradual damage monotonically accumulating 
over time in a sequence of tiny increments, such as wear, fatigue, degrading health index etc., In the application 
part the premenstrual syndrome has been proposed to result from excessive exposure to and or withdrawal of 
brain opioid activity during the luteal phase.  The changes in the luteal LH pulse frequency failed to provide 
evidence that GnRH secretion is impaired, thus challenging the view that the neuroregulation of the menstrual 
cycle in women with PMS is markedly altered.  The mathematical model has been proposed that for women 
suffering  from  severe,  long  term  premenstrual  symptoms,  the  symptom  free  interval  associated  with  the 
follicular phase is compromised by the feelings of guilt and depression for neglect of families and professional 
responsibilities. 
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I.  Mathematical Model 
Let the amount of damage in the k
th shock is 
denoted as Xk which is treated as a positive random 
variable.  The total damage observed up to time t is 
the  sum  of  the  increments            ? ?  = ?1 + ?2 +
?3 + ………………+ ?? .  The  number  of  damage 
increments in the interval (0, t) need not be a fixed 
number.    The  uncertain  arrival  of  shocks  can  be 
modeled  as  a  Poisson  process,  referred  to  as  a 
compound  process  [21].    When  degradation  takes 
place  in  very  small  increments  almost  continuously 
over time, a simpler and effective stochastic model of 
degradation can be derived as a limiting form of the 
compound  Poisson  process.    The  limiting  form  is 
obtained  when  the  rate  of  damage  occurrence 
approaches infinity in any finite time interval as the 
size of the increment tends to zero.  Such a stochastic 
process is referred to as a gamma process because the 
cumulative damage up to time t follows the gamma 
distribution.  The gamma process is suitable to model 
gradual  damage  monotonically  accumulating  over 
time in a sequence of tiny increments, such as wear, 
fatigue, degrading health index etc.,  
A  random  quantity  X  has  a  gamma 
distribution  with  shape  parameter  V  >  0  and  scale 
parameter U >0 if its probability density function is 
given by  
?𝑎 ?\v,u  = 
??
 ? 
x?−1exp −?? I 0,∞ (x) 
𝐼𝐴 ?  =   1 ??? ? ∈ 𝐴 𝑎?? 𝐼𝐴  ?  = 0 ??? ? ∉ 𝐴   and   
 𝑎  =    ?𝗼−1 ∞
?=0 ?−???  is the gamma function for 
ʱ>1.    Using  moment  generating  functions  it  can  be 
proved  that  the  expectation  and  the  variance  of  the 
process  X(t)  are  given  by  ? ? ?   = 
??
?    and  
𝑉𝑎? ? ?   =  
??
?2 . 
Assuming that the expectation and variance 
are linear in time, i.e., ? ? ?   =  𝜇?,   𝑉𝑎? ? ?   =
  𝜎2? .  Then the parameters of the process X (t) are 
defined as   
?  =
𝜇2
𝜎2   𝑎??  ? = 
𝜇
𝜎2  Where  µ  is  the  average 
deterioration rate and 𝜎2 is the variance of the process.  
Thus, when the expected deterioration is linear over 
time, it is convenient to rewrite the probability density 
function of X(t) as  
? 1? ?  ?  = ?𝑎 ? − 1 
 𝜇2? 
𝜎2 ,𝜇/𝜎2 ,???  𝜇,𝜎 > 0 
The  two  parameters  expectation  and  the 
variance are uncertain and assessing both variables for 
each individual component is very cumbersome.  In 
order  to  keep  the  method  practical,  the  standard 
deviation    may  be  mixed  relative  to  the  mean  µ 
through  the  use  of  a  coefficient  of  variation  ?.  
RESEARCH ARTICLE                                                                               OPEN ACCESS Dr. S. Lakshmi et al Int. Journal of Engineering Research and Applications                  www.ijera.com 
ISSN : 2248-9622, Vol. 4, Issue 1( Version 1), January 2014, pp.182-186 
 
 
www.ijera.com                                                                                                                              183 | P a g e  
Hence, =  ? 𝜇 ⟹ ? = 
𝜎
𝜇 .  Therefore, the probability 
density  function  for  X(t)  reduces  to  ? 1? ?  ?  =
?𝑎 ? − 1 ? ?2   ,1/(𝜇?2) . 
Let X(t) denote the deterioration at time t, t  
0.  A component is said to fail when its deteriorating 
resistance,  denoted  by  𝑅 ?  =  rₒ− X t ,  drops 
below the stress s.  We assume that both the initial 
resistance  rₒ  and  the  stress  to  be  fixed.    Define 
? =  rₒ− s and let the time at which failure occurs be 
denoted by the life time.  The life time distribution can 
be rewritten as  
? ?  =  𝑃? 𝑇? ≤ ?  = 𝑃? ?(?) ≥ ?  
  ? ? ?  ? ??  = 
(
 𝜇2? 
𝜎2  ,
 ?𝜇 
𝜎2 )
(
 𝜇2? 
𝜎2 )
∞
?=?
 
For computing the probability density function of the 
time to failure for a stationary gamma process,   
? ?  = 𝑃? ? ?  ≥ ?  ≈ ʦ 
μt − y
σ t
  
=  ʦ  
yμ
σ2   
μt
y −  
y
μt  . 
Where ʦ is the cumulative distribution function of the 
standard normal distribution. 
The  stationarity  of  the  gamma  process 
basically follows from the property that increments are 
independent and have the same type of distribution as 
their sum. A random variable X is infinitely divisible 
if for any integer n  2, there are n independent and 
identically  distributed  random  variables 
?1
(?) …………..??
(?) such that their sum   ?𝑖
(?) ?
𝑖=1  as 
the  same  distribution  as  X.    In  terms  of  Laplace 
transforms, the definition of infinite divisibility can be 
formulated as:  (?−??) =    ?  ?−??𝑖
 ? 
   ?
𝑖=1  ,? ≥ 2 .  
In fact every infinitely divisible distribution is a limit 
of compound Poisson distributions. 
An important property of the gamma process 
is that it is a jump process.  The gamma process can be 
regarded as a compound Poisson process of gamma-
distributed increments in which the Poisson rate tends 
to  infinity  and  increment  sizes  tend  to  zero  in 
proportion.    Using  the  technique  of  Laplace 
transforms, it can be shown that the gamma process 
can be reformulated in terms of a limit of a compound 
Poisson process. 
The  cumulative  distribution  function  of  the 
total  deterioration  in  time  -  interval   0,n∆ , n =
1,……………,N − 1 ,  is  the  beta  distribution  in 
?
𝑁𝜃 
with parameters n and N-n [10]:  
𝑃?    ?𝑖 ≤ ? ?
𝑖=1  
1
𝑁  ?𝑖
𝑁
𝑖=1 = 𝜃  =
1 −    
𝑁−1
𝑖−1  ?
𝑖=1  1 −
?
𝑁𝜃 
𝑁−𝑖
 
?
𝑁𝜃 
𝑖−1
, 
For  y    0  and  0  otherwise.    The  beta  function 
coincides with the cumulative distribution function of 
the  n
th  order  statistic  of  (N-1)  independent  and 
identical  distributed  random  quantities  with  uniform 
distribution  on  [0,  N
θ].    The  beta  distribution 
converges to the gamma distribution with parameters 
n and θ for y  0 
𝑃?    ?𝑖 ≤ ? ?
𝑖=1  
1
𝑁  ?𝑖
𝑁
𝑖=1 = 𝜃  → 1 −
 
1
 𝑖−1 !
?
𝑖=1  
?
𝜃 
𝑖−1
??? −
?
𝜃  . 
 
II.  Application 
2.1 Introduction   
The  mechanisms  involved  in  producing  the 
complex  of  symptoms  collectively  termed  the 
premenstrual  syndrome  (PMS)  are  unknown.    The 
failure  to  identify  gross  aberrations  in  plasma 
concentrations of the reproductive hormones had led 
investigators to search for a common link between the 
dynamic  neuroendocrine  secretory  events  that 
characterize  the  menstrual  cycle  and  central 
mechanisms regulating behavior and mood states.  It 
has been proposed that premenstrual symptoms occur 
in response to the cyclic rise and fall in hypothalamic 
opioid  activity  believed  to  modulate  the  pulsatile 
release of gonadotropin – releasing hormone (GnRH) 
and, in turn, luteinizing hormone (LH), as a result of 
the characteristic changes in the ovarian production of 
the estrogen and progesterone [9],  [14].  Advocates 
propose  that  the  withdrawal  of  high  opioid  activity 
prior to menses disinhibits opioid – sensitive neurons, 
resulting in such dysphoric symptoms as irritability, 
insomnia, food cravings, anxiety, and pain sensitivity 
[3], [6] & [7].  LH pulse frequency in the mid – luteal 
(ML)  phase  has  been  reported  to  be  faster  in  PMS 
patients, despite similar concentrations of P compared 
to  normal  volunteers  [7].  This  finding  as  well  as 
earlier evidence that LH responsiveness to the opiate 
antagonist, naloxone, was blunted in PMS patients [6] 
prompted these investigators to propose that PMS was 
a central disorder, due to a hypothalamic impairment 
of the opioid inhibition normally present at this time in 
the  cycle.    Differences  in  LH  pulse  frequency  and 
amplitude between the patient and control groups in 
the later study [7] were small, however, and secretory 
characteristics  were  within  the  normal  range  of 
variability previously reported for normal, asymptotic 
women  [13].  In  addition,  these  investigators  noted 
that the presence of secondary psychiatric disorders in 
some of the PMS subjects may have confounded their 
results. 
 
2.2 Symptom Characteristics during Study: 
In  both  the  premenstrual  and  the 
premenstrual weeks of the study cycle, the volunteer 
group demonstrated a lower mean symptom score than 
the patient group.  Mean age and cycle length were 
similar.    Since  underlying  psychiatric  disorders  had 
been  ruled  out  during  the  diagnostic  evaluation,  the 
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more likely reflected the chronic nature and severity 
of  the  menstrual  health  problem.    Little  is  known 
about how PMS symptom patterns change over time, 
especially in women who fail to benefit from standard 
treatment approaches.  It has been proposed that for 
women  suffering  from  severe,  long  –  term 
premenstrual  symptoms,  the  “symptom  –  free” 
interval  associated  with  the  follicular  phase  is 
compromised by feelings of guilt and depression for 
neglect of family and professional responsibilities. 
 
Fig.2.2.1: Plasma gonadotropin and ovarian steroids during 8 – hr rapid  - sampling studies in the EF, ML and 
LL phases of the menstrual cycle in two subjects with PMS *=LH pulse.  E2 and P values shown are for the 
beginning and end of the rapid – sampling periods. 
 
Mean plasma FSH was different in the PMS 
and control groups mean FSH was higher in the PMS 
patients in the ML studies. 
 
2.3 Discussion 
We studied changes in pulsatile LH secreted 
in women with PMS to detect peripheral evidence of 
alterations in the transient increase and withdrawal of 
endogenous opioid action on GnRH secretion during 
ovulatory,  symptomatic  cycles.    We  chose  three 
different  “windows”  in  the  menstrual  cycle  which 
have  been  characterized  previously  in  relation  to 
ovarian  steroids,  gonadotropin  secretion,  menstrual 
symptomatology, and presumed opioid activity.  The 
current view of the hormonal interrelationships in the 
normal luteal phase is that P in the presence of E2 acts 
on  the  hypothalamus  to  transiently  increase  opioid 
activity,  thus  inhibiting  the  frequency  of  pulsatile 
GnRH secretion and in turn the pulsatile release of LH 
[19],  [2],  [8]  &  [16].    With  the  fall  in  E2  and  P 
secretion  from  the  aging  corpus  luteum,  opioid 
exposure  is  withdrawn,  allowing  GnRH  pulsatile 
secretion  to  increase  in  the  days  preceding  menses 
[11].    Thus,  assessment  of  LH  pulse  frequency  in 
women  has  been  used  to  infer  changes  in  GnRH 
secretion  and  may  allow  a  gross  estimation  of 
hypothalamic opioid influence when performed in the  
 
Presence  of  a  well  –  defined  ovarian  steroid 
milieu.These  results  provide  evidence  that  the 
symptoms of PMS can occur in the absence of marked 
abnormalities  in  the  neuroreproductive  axis  and 
challenge  the  view  that  opioid  inhibition  of  GnRH 
secretion is impaired.  These findings, however, do not 
rule out aberrations in other steroid – mediated opioid 
action external to the hypothalamus that could play a 
role  in  the  emotional  and  cognitive  symptoms 
associated with this disorder. 
This  finding  further  strengthens  evidence 
from  studies  of  daily  hormone  measures  that  the 
ability to secrete ovulatory levels of ovarian steroids is 
not compromised in PMS [15].  Moreover, our finding 
that  peripheral  plasma  P  concentrations  bear  no 
relationship to PMS symptom severity fails to support 
the  use  of  ovarian  steroids  in  the  treatment  of  the 
disorder. 
 
III.  Mathematical Results 
A useful property of the gamma process with 
stationary  increments  is  that  the  gamma  density 
transforms  into  an  exponential  density  if    ? =
 𝜎 𝜇    2.  When the unit – time length is chosen to be 
 𝜎 𝜇    2,  the  increments  of  deterioration  are 
exponentially  distributed  with  mean  
2/µ.    The 
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Poisson distribution with mean 1 +  ?𝜇  𝜎2    is given 
by [18],  ?𝑖 =
1
 𝑖 − 1 !
 
?𝜇
𝜎2 
𝑖−1
??? −
?𝜇
𝜎2  ,                  𝑖
= 1,,2,3,…………… 
       
    Fig 3.1        Fig 3.2          Fig 3.3 
 
     
    Fig 3.4        Fig 3.5          Fig 3.6 
 
A physical explanation for the appearance of 
the above Poisson distribution is that it represents the 
probability  that  exactly  i  exponentially  distributed 
jumps with mean 
2 / µ cause the component to fail, 
that is, cause the cumulative amount of deterioration 
to exceed  rₒ - s.  Note that the smaller the unit-time 
length  for  which  the  increments  are  exponentially 
distributed,  the  less  uncertain  the  deterioration 
process. 
 
IV.  Conclusion 
In  both  the  premenstrual  and  the 
premenstrual weeks of the study cycle, the volunteer 
group demonstrated a lower mean symptom score than 
the patient group.  Mean age and cycle length were 
similar.    Since  underlying  psychiatric  disorders  had 
been  ruled  out  during  the  diagnostic  evaluation,  the 
higher “baseline” scores of the postmenopausal week 
more likely reflected the chronic nature and severity 
of  the  menstrual  health  problem.    Little  is  known 
about how PMS symptom patterns change over time, 
especially in women who fail to benefit from standard 
treatment approaches.  Hence, to find the time interval 
the  Compound  Poisson  Process  is  utilized  and  the 
corresponding mathematical figures in section 3 have 
been obtained which show that in all the cases at the 
end of 15
th hour the impairment is vanished for all the 
variables  of  the  above  two  subjects  taken  into 
consideration.  
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